Document:

Exhibit 10.4

 

ATLAS CREST INVESTMENT CORP. II

399 Park Avenue

New York, NY 10022

 

February 3 , 2021

 

Moelis & Company LLC

399 Park Avenue

New York, NY 10022

 

		Re:	Support Agreement

 

Ladies and Gentlemen:

 

1. This letter agreement
by and between Atlas Crest Investment Corp. II (the “Company”) and Moelis & Company LLC (“Moelis”),
dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed
on The New York Stock Exchange (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus
filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier
of the consummation by the Company of an initial business combination or the Company’s liquidation (in each case as described
in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):

 

(i) Moelis shall make available, or cause
to be made available, to the Company, at 399 Park Avenue, New York, New York 10022 (or any successor location of Moelis), certain
office space and secretarial and administrative services as may be reasonably required by the Company; and

 

(ii) Moelis, or its parent, Moelis & Company
Group LP, shall make available certain corporate development and other operational support, including accounting and legal services,
as may be reasonably required by the Company (the services set forth in clauses (i) and (ii) are referred to herein as, the “Services”).

 

In exchange therefor, the Company shall
pay Moelis the sum of $10,000 per month on the Listing Date and continuing monthly thereafter until the Termination Date.

 

2. We are an independent
contractor (and we are expressly not acting as a fiduciary) with the contractual duties described herein owing only to the Company.
Since we will be acting on the Company’s behalf, the Company and we agree to the indemnity and other provisions set forth
in Annex A. The Company’s obligations set forth therein shall be in addition to any rights that any Indemnified
Person may have at common law or otherwise. Other than the Indemnified Persons, there are no third-party beneficiaries of this
agreement.

 

3. Either of us may
terminate this agreement at any time, with or without cause, on written notice. In the event of any termination, we will
continue to be entitled to the fees that became payable hereunder prior to termination. Annex A, Sections 2 through 6 shall
remain in full force and effect after the completion or termination of this agreement.

 

4. Moelis is an independent
investment bank which is engaged in a range of investment banking activities. Certain affiliates of Moelis are engaged in asset
management and other activities for their own account and otherwise. Moelis and its affiliates may have interests that differ from
the Company’s interests. Moelis and its affiliates have no duty to disclose to the Company, or use for the Company’s
benefit, any information acquired in the course of providing services to any other party, engaging in any transaction or carrying
on any other businesses. Moelis’ employees, officers, partners and affiliates may at any time own the Company’s securities
or those of any other entity involved in any transaction contemplated by this agreement. Moelis recognizes its obligations under
applicable securities laws in connection with the purchase and sale of such securities. The provision of the Services by Moelis
to the Company as set forth herein or the entry into this agreement by Moelis with the Company shall not restrict or prevent Moelis
from acting as a financial advisor, placement agent or investment banker to any other party, including without limitation, (i)
to a party that is the counterparty in an initial business combination contemplated or to be consummated by the Company or (ii)
another special purpose acquisition company evaluating the same or similar initial business combination as the Company .

 

     

     

    

 

5. Moelis hereby irrevocably
waives any and all right, title, interest, causes of action and claims of any kind as a result of, or arising out of, this letter
agreement (each, a “Claim”) in or to, and any and all right to seek payment of any amounts due to it out of, the trust
account established for the benefit of the public stockholders of the Company and into which substantially all of the proceeds
of the Company’s initial public offering will be deposited (the “Trust Account”) as a result of, or arising out
of, this letter agreement, and hereby irrevocably waives any Claim it may have in the future, which Claim would reduce, encumber
or otherwise adversely affect the Trust Account or any monies or other assets in the Trust Account, and further agrees not to seek
recourse, reimbursement, payment or satisfaction of any Claim against the Trust Account or any monies or other assets in the Trust
Account for any reason whatsoever.

 

6. This agreement and
any disputes or claims that may arise out of this agreement shall be governed by and construed in accordance with the internal
laws of the State of New York, and this agreement embodies the entire agreement and supersedes any prior written or oral agreement
relating to the subject matter hereof, and may only be amended or waived in writing signed by both the Company and us. If any part
of this agreement is judicially determined to be unenforceable, it shall be interpreted to the fullest extent enforceable so as
to give the closest meaning to its intent and the remainder of this agreement shall continue in full force and effect. Any proceeding
arising out of this agreement shall be heard exclusively in a New York state or federal court sitting in the city and county of
New York, to whose jurisdiction and forum Moelis and the Company irrevocably submit. The Company also irrevocably consents to the
service of process in any such proceeding by mail to the Company’s address set forth above. This agreement may be executed
in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same agreement.
This agreement shall be binding upon the Company and us and its and our respective successors and assigns. WE AND THE COMPANY (ON
ITS OWN BEHALF AND, TO THE EXTENT PERMITTED BY APPLICABLE LAW, ON BEHALF OF ITS SECURITY HOLDERS) WAIVE ANY RIGHT TO TRIAL BY JURY
WITH RESPECT TO ANY PROCEEDING ARISING OUT OF THIS AGREEMENT.

 

(Signature page follows)

 

    2

     

    

 

 

	 	Very truly yours,
	 	 	 
	 	ATLAS CREST INVESTMENT CORP. II
	 	 	 
	 	By:	/s/ Michael Spellacy
	 	 	Name: 	Michael Spellacy
	 	 	Title: 	Chief Executive Officer
	 	 	 
	 	MOELIS & COMPANY LLC
	 	 	 
	 	 By: 	/s/ Ken Moelis
	 	 	Name:	Ken Moelis
	 	 	Title: 	Chief Executive Officer

 

[Services Agreement Signature Page]

 

    3

     

    

 

ANNEX A

 

In the event that Moelis & Company
LLC or our affiliates or any of our or our affiliates’ respective current or former directors, officers, partners, managers,
agents, representatives or employees (including any person controlling us or any of our affiliates) (collectively, “Indemnified
Persons”) becomes involved in any capacity in any actual or threatened action, claim, suit, investigation or proceeding (an
“Action”) arising out of, related to or in connection with this agreement or any matter referred to herein, the Company
will reimburse such Indemnified Person for the reasonable out-of-pocket costs and expenses (including counsel fees) of investigating,
preparing for and responding to such Action or enforcing this agreement, as they are incurred. The Company will also indemnify
and hold harmless any Indemnified Person from and against, and the Company agrees that no Indemnified Person shall have any liability
to the Company or its affiliates, or their respective owners, directors, officers, employees, security holders or creditors for,
any losses, claims, damages or liabilities (collectively, “Losses”) (A) related to or arising out of oral or written
statements or omissions made or information provided by the Company or its agents or (B) otherwise arising out of, related to or
in connection with this agreement or our performance thereof, except that this clause (B) shall not apply to Losses that are finally
judicially determined to have resulted primarily from the bad faith or gross negligence of such Indemnified Person.

 

If such indemnification or limitation on
liability are for any reason not available or insufficient to hold an Indemnified Person harmless, the Company agrees to contribute
to the Losses in such proportion as is appropriate to reflect the relative benefits received (or anticipated to be received) by
the Company, on the one hand, and by us, on the other hand, with respect to this agreement or, if such allocation is judicially
determined to be unavailable, in such proportion as is appropriate to reflect the relative benefits and relative fault of the Company
on the one hand and of us on the other hand, and any other equitable considerations; provided, however, that, to the extent permitted
by applicable law, in no event shall the Indemnified Persons be responsible for amounts that exceed the fees actually received
by us from the Company in connection with this agreement. Relative benefits to the Company, on the one hand, and us, on the other
hand, with respect to this agreement shall be deemed to be in the same proportion as (i) the total value paid or proposed to be
paid or received or proposed to be received by the Company or its security holders, as the case may be, pursuant to the Transaction(s),
whether or not consummated, bears to (ii) the fees actually received by us in connection with this agreement.

 

The Company will not, without our prior
written consent (not to be unreasonably withheld), settle, compromise, consent to the entry of any judgment in or otherwise seek
to terminate (a “Settlement”) any Action in respect of which indemnification is or may be sought hereunder (whether
or not an Indemnified Person is a party thereto) unless such Settlement includes a release of each Indemnified Person from any
Losses arising out of such Action. The Company will not permit any such Settlement to include a statement as to, or an admission
of, fault or culpability by or on behalf of an Indemnified Person without such Indemnified Person’s prior written consent.
No Indemnified Person seeking indemnification, reimbursement or contribution under this agreement will, without the Company’s
prior written consent (not to be unreasonably withheld), agree to the Settlement of any Action.

 

Prior to effecting any proposed sale, exchange,
dividend or other distribution or liquidation of all or substantially all of its assets or any significant recapitalization or
reclassification of its outstanding securities that does not explicitly or by operation of law provide for the assumption of the
obligations of the Company set forth herein, the Company will notify us in writing of its arrangements for the Company’s
obligations set forth herein to be assumed by another creditworthy party (for example through insurance, surety bonds or the creation
of an escrow) upon terms and conditions reasonably satisfactory to the Company and us.Exhibit 10.5

 

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT

 

THIS PRIVATE PLACEMENT
WARRANTS PURCHASE AGREEMENT, dated as of February 3, 2021 (as it may from time to time be amended and including all exhibits referenced
herein, this “Agreement”), is entered into by and between Atlas Crest Investment Corp. II, a Delaware corporation
(the “Company”), and Atlas Crest Investment II LLC, a Delaware limited liability company (the “Purchaser”).

 

WHEREAS, the Company
intends to consummate an initial public offering of the Company’s units (the “Public Offering”), each
unit consisting of one share of the Company’s Class A common stock, par value $0.0001 per share (each, a “Share”),
and one-fourth of one redeemable warrant. Each whole warrant entitles the holder to purchase one Share at an exercise price
of $11.50 per Share. The Purchaser has agreed to purchase an aggregate of 5,333,333 warrants (or up to 5,933,333 warrants if the
over-allotment option in connection with the Public Offering is exercised in full) (the “Private Placement Warrants”),
each Private Placement Warrant entitling the holder to purchase one Share at an exercise price of $11.50 per Share.

 

NOW THEREFORE, in
consideration of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1.
Authorization, Purchase and Sale; Terms of the Private Placement Warrants.

 

A. Authorization
of the Private Placement Warrants. The Company has duly authorized the issuance and sale of the Private Placement Warrants
to the Purchaser.

 

B. Purchase
and Sale of the Private Placement Warrants.

 

On the date of the
consummation of the Public Offering and concurrently with the consummation thereof, or on such earlier time and date as may be
mutually agreed by the Purchaser and the Company (the “Initial Closing Date”), the Company shall issue and sell
to the Purchaser, and the Purchaser shall purchase from the Company, 5,333,333 Private Placement Warrants at a price of $1.50 per
warrant for an aggregate purchase price of $8,000,000 (the “Purchase Price”). The Purchase Price shall be paid
by wire transfer of immediately available funds to the Company in accordance with the Company’s wiring instructions at least
one business day prior to the date of effectiveness of the registration statements on Form S-1, (File Nos. 333-251893
and 333-252709) filed in connection with the Public Offering. On the Initial Closing Date, the Company, shall either, at its option,
deliver a certificate evidencing the Private Placement Warrants purchased by the Purchaser on such date duly registered in the
Purchaser’s name to the Purchaser, or effect such delivery in book-entry form. On the date of the consummation of the closing
of the over-allotment option in connection with the Public Offering, and concurrently with the consummation thereof, or on such
earlier time and date as may be mutually agreed by the Purchaser and the Company (each such date, an “Over-allotment Closing
Date”; together with the Initial Closing Date, the “Closing Dates” and each, a “Closing Date”),
the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, up to an aggregate of 600,000
Private Placement Warrants, in the same proportion as the amount of the over-allotment option that is exercised, at a price of
$1.50 per warrant for an aggregate purchase price of up to $900,000 (if the over-allotment option in connection with the Public
Offering is exercised in full) (the “Over-allotment Purchase Price”), which shall be paid by wire transfer
of immediately available funds to the Company in accordance with the Company’s wiring instructions. On the Over-allotment
Closing Date, upon the payment by the Purchaser of the Over-allotment Purchase Price payable by it by wire transfer of immediately
available funds to the Company, the Company shall either, at its option, deliver a certificate evidencing the Private Placement
Warrants purchased by the Purchaser on such date duly registered in the Purchaser’s name to the Purchaser, or effect such
delivery in book-entry form.

 

     

     

    

 

C. Terms of
the Private Placement Warrants.

 

(i) The Private Placement
Warrants shall have their terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in connection
with the Public Offering (a “Warrant Agreement”).

 

(ii) At or prior to
the time of the Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement (the “Registration
Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser relating to
the Private Placement Warrants and the Shares underlying the Private Placement Warrants.

 

Section 2.
Representations and Warranties of the Company. As a material inducement to the Purchaser to enter into this Agreement
and purchase the Private Placement Warrants, the Company hereby represents and warrants to the Purchaser (which representations
and warranties shall survive each Closing Date) that:

 

A. Organization
and Corporate Power. The Company is a corporation duly organized, validly existing and in good standing under the laws of the
State of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be
expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company
possesses all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement and
the Warrant Agreement.

 

B. Authorization;
No Breach.

 

(i) The execution,
delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized and approved by the Company
as of each Closing Date. This Agreement constitutes a valid and binding obligation of the Company, enforceable in accordance with
its terms. Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the
Private Placement Warrants will constitute valid and binding obligations of the Company, enforceable in accordance with their terms.

 

(ii) The execution
and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement
Warrants, the issuance of the Shares upon exercise of the Private Placement Warrants and the fulfillment of, and compliance with,
the respective terms hereof and thereof by the Company, do not and will not as of each Closing Date (a) conflict with or result
in a breach of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of
any lien, security interest, charge or encumbrance upon the Company’s capital stock or assets under, (d) result in a
violation of, or (e) require any authorization, consent, approval, exemption, action, notice, declaration or filing, in each
case, by or to any court or administrative or governmental body or agency pursuant to the certificate of incorporation or the bylaws
of the Company (in effect on the date hereof or as may be amended prior to completion of the contemplated Public Offering), or
any material law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment or decree to which
the Company is subject, except for any filings required after the date hereof under federal or state securities laws.

 

C. Title to
Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Placement
Warrants will be duly and validly issued and the Shares issuable upon exercise of the Private Placement Warrants will be duly and
validly issued, fully paid and nonassessable. On the date of issuance of the Placement Warrants, the Shares issuable upon exercise
of the Placement Warrants shall have been reserved for issuance. Upon issuance in accordance with, and payment pursuant to, the
terms hereof and the Warrant Agreement, the Purchaser will have good title to the Private Placement Warrants and the Shares issuable
upon exercise of such Private Placement Warrants, free and clear of all liens, claims and encumbrances of any kind, other than
(i) transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under
federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

 

D. Valid Issuance.
The total number of shares of all classes of capital stock which the Company has authority to issue is 220,000,000 shares of common
stock (which consist of 200,000,000 shares of the Company’s Class A Common Stock and 20,000,000 shares of the Company’s
Class B common stock, par value $0.0001 per share (the “Class B Common Stock”)) and 1,000,000 shares of the
Company’s preferred stock, par value $0.0001, per share (the “Preferred Stock”). As of the date hereof,
the Company has issued and outstanding no shares of Class A Common Stock, 8,625,000 shares of Class B Common Stock (of which up
to 1,125,000 shares are subject to forfeiture as described in the Registration Statement) and no shares of Preferred Stock. All
of the issued shares of capital stock of the Company have been duly authorized, validly issued, and are fully paid and non-assessable.

 

    2

     

    

 

E. Governmental
Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is
required in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the
Company of any other transactions contemplated hereby.

 

Section 3.
Representations and Warranties of the Purchaser. As a material inducement to the Company to enter into this Agreement
and issue and sell the Private Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company
(which representations and warranties shall survive each Closing Date) that:

 

A. Organization
and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions
contemplated by this Agreement.

 

B. Authorization;
No Breach.

 

(i) This Agreement
constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’
rights and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii) The execution
and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does
not and shall not as of each Closing Date conflict with or result in a breach by the Purchaser of the terms, conditions or provisions
of any agreement, instrument, order, judgment or decree to which the Purchaser is subject that would materially impact its ability
to perform its obligations hereunder.

 

C. Investment
Representations.

 

(i) The Purchaser
is acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable upon such
exercise (collectively, the “Securities”), for the Purchaser’s own account, for investment purposes only
and not with a view towards, or for resale in connection with, any public sale or distribution thereof.

 

(ii) The Purchaser
is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D of the Securities Act of 1933,
as amended (the “Securities Act”).

 

(iii) The Purchaser
understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration
requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy
of, and the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth herein in order to
determine the availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv) The Purchaser
did not enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule 502(c)
under the Securities Act.

 

(v) The Purchaser
has been furnished with all materials relating to the business, finances and operations of the Company and materials relating to
the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity
to ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities
involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an
informed investment decision with respect to the acquisition of the Securities.

 

(vi) The Purchaser
understands that no United States federal or state agency or any other government or governmental agency has passed on or made
any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser
nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

    3

     

    

 

(vii) The Purchaser
understands that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities
laws, and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold
in reliance on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither
the Company nor any other person is under any obligation to register the Securities under the Securities Act or any state securities
laws or to comply with the terms and conditions of any exemption thereunder. While the Purchaser understands that Rule 144 under
the Securities Act is not available for the resale of securities initially issued by shell companies (other than business combination
related shell companies) or issuers that have been at any time previously a shell company, the Purchaser understands that Rule
144 includes an exception to this prohibition if the following conditions are met: (i) the issuer of the securities that was
formerly a shell company has ceased to be a shell company; (ii) the issuer of the securities is subject to the reporting requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”); (iii) the
issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding
12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports;
and (iv) at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting
its status as an entity that is not a shell company.

 

(viii) The Purchaser
has knowledge and experience in financial and business matters, understands the high degree of risk associated with investments
in the securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an
investment in the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated
hereunder for an indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies
and will have no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities.
The Purchaser can afford a complete loss of its investment in the Securities.

 

Section 4.
Conditions of the Purchaser’s Obligations. The obligations of the Purchaser to purchase and pay for the Private
Placement Warrants are subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

A. Representations
and Warranties. The representations and warranties of the Company contained in Section 2 shall be true and correct at
and as of such Closing Date as though then made.

 

B. Performance.
The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that
are required to be performed or complied with by it on or before such Closing Date.

 

C. No Injunction.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

D. Warrant
Agreement and Registration Rights Agreement. The Company shall have entered into a Warrant Agreement with a warrant agent and
the Registration Rights Agreement, each on terms satisfactory to the Purchaser.

 

E. Corporate
Consents. The Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance
of this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.

 

Section 5.
Conditions of the Company’s Obligations. The obligations of the Company to the Purchaser under this Agreement are
subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

A. Representations
and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall be true and correct at
and as of such Closing Date as though then made.

 

B. Performance.
The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that
are required to be performed or complied with by the Purchaser on or before such Closing Date.

 

    4

     

    

 

C. Corporate
Consents. The Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance
of this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.

 

D. No Injunction.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

E. Warrant
Agreement. The Company shall have entered into a Warrant Agreement with a warrant agent on terms satisfactory to the Company.

 

Section 6.
Termination. This Agreement may be terminated at any time after June 30, 2021 upon the election by either the Company
or the Purchaser upon written notice to the other party if the closing of the Public Offering does not occur prior to such date.

 

Section 7. Survival
of Representations and Warranties. All of the representations and warranties contained herein shall survive each Closing
Date.

 

Section 8. Definitions. Terms
used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the registration statement on
Form S-1 the Company has filed with the Securities and Exchange Commission under the Securities Act in connection with
the Public Offering.

 

Section 9.
Miscellaneous.

 

A. Successors
and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or
on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether
so expressed or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement
without the prior written consent of the other party hereto, other than assignments by the Purchaser to its affiliates (including,
without limitation, one or more of its members).

 

B. Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be
ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

C. Counterparts.
This Agreement may be executed simultaneously in two or more counterparts, none of which needs to contain the signatures of more
than one party, but all such counterparts taken together shall constitute one and the same agreement. In the event that any signature
is delivered by facsimile transmission or by e-mail delivery of a “pdf” format data file, such signature
shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same
force and effect as if such facsimile or “.pdf” signature page were an original thereof.

 

D. Descriptive
Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not constitute
a substantive part of this Agreement. The use of the word “including” in this Agreement shall be by way of example
rather than by limitation.

 

E. Governing
Law. This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall
be construed in accordance with the internal laws of the State of New York, without regard to the conflicts of laws principles
thereof.

 

F. Amendments.
This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by
all parties hereto.

 

[Signature Page Follows]

 

    5

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	ATLAS CREST INVESTMENT CORP. II,

a Delaware corporation
	 	 	 
	 	By:	/s/ Michael Spellacy
	 	 	Name: 	Michael Spellacy
	 	 	Title:	Chief Executive Officer

 

	 	PURCHASER:
	 	 
	 	ATLAS CREST INVESTMENT II LLC,

a Delaware limited liability company
	 	 	 
	 	By:	/s/ Kenneth Moelis
	 	 	Name: 	Kenneth Moelis
	 	 	Title:	Managing Member

 

[Signature Page to Private Placement
Warrants Purchase Agreement]

 

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]